Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» weightloss
weightloss
Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug
Biohaven hopes to muscle in on Ozempic with a different type of weight loss drug
BioPharma Dive
Biohaven
weightloss
Ozempic
Wegovy
Flag link:
The Next Generation of Weight Loss Drugs is Rapidly Approaching
The Next Generation of Weight Loss Drugs is Rapidly Approaching
BioSpace
weightloss
Novo Nordisk
Eli Lilly
Pfizer
AstraZeneca
Wegovy
Zepbound
Flag link:
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weightloss
Flag link:
How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets
How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets
Medical Marketing and Media
Eli Lilly
tirzepatide
weightloss
Zepbound
Mounjaro
Flag link:
Senator floats new models to manage costs of weight loss drugs like Ozempic
Senator floats new models to manage costs of weight loss drugs like Ozempic
Stat
Novo Nordisk
Wegovy
Ozempic
weightloss
Senate
drug pricing
Flag link:
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
Motley Fool
Novo Nordisk
Wegovy
weightloss
Flag link:
FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management
FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management
BioSpace
Eli Lilly
Zepbound
FDA
weightloss
Flag link:
Noom to offer prescriptions for weight-loss drugs
Noom to offer prescriptions for weight-loss drugs
Yahoo Finance
Noom
weightloss
Novo Nordisk
Eli Lilly
Wegovy
Ozempic
Mounjaro
Flag link: